CRBU
Caribou Biosciences, Inc.
Company overview
- Market capitalization
- $131.87M
- Employees
- 97
- Latest publication
- 2026-09-29
About Caribou Biosciences, Inc.
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,499,000USD | 2,397,000USD | 3,941,000USD | 2,198,000USD | 2,667,000USD | 2,353,000USD | 2,077,000USD | 2,024,000USD |
| Research Development | 18,942,000USD | 20,611,000USD | 23,815,000USD | 22,401,000USD | 27,692,000USD | 35,531,000USD | 30,464,000USD | 30,421,000USD |
| Selling General Administrative | 7,896,000USD | 8,066,000USD | 8,579,000USD | 9,197,000USD | 10,403,000USD | 9,735,000USD | 10,488,000USD | 9,841,000USD |
| General And Administrative Expenses | 7,896,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 26,838,000USD | 28,028,000USD | 32,394,000USD | 31,598,000USD | 50,245,000USD | 45,266,000USD | 11,088,000USD | 40,262,000USD |
| Operating Income | -25,339,000USD | -26,280,000USD | -28,453,000USD | -29,400,000USD | -47,578,000USD | -42,913,000USD | -38,875,000USD | -38,238,000USD |
| Total Other Income Expense Net | 1,057,000USD | 1,195,000USD | 1,415,000USD | 1,852,000USD | -6,520,000USD | 2,922,000USD | 3,376,000USD | 3,554,000USD |
| Net Income | -24,282,000USD | -25,085,000USD | -26,488,000USD | -27,548,000USD | -54,098,000USD | -39,991,000USD | -35,490,000USD | -34,684,000USD |
| Cost Of Revenue | — | 649,000USD | 682,000USD | 631,000USD | — | — | 29,864,000USD | 1,177,000USD |
| Gross Profit | — | 1,748,000USD | 3,941,000USD | 2,198,000USD | 2,667,000USD | 2,353,000USD | -27,787,000USD | 2,024,000USD |
| Income Before Tax | — | -25,085,000USD | -27,038,000USD | -27,548,000USD | -54,098,000USD | -39,991,000USD | -35,499,000USD | -34,684,000USD |
| Net Income From Continuing Ops | — | -25,085,000USD | -26,488,000USD | -27,548,000USD | -54,098,000USD | -39,991,000USD | -35,490,000USD | -34,684,000USD |
| Ebit | — | -26,280,000USD | -28,453,000USD | -29,400,000USD | -35,428,000USD | -42,913,000USD | -38,275,000USD | -38,238,000USD |
| Ebitda | — | -25,631,000USD | -27,771,000USD | -28,769,000USD | -34,261,000USD | -41,748,000USD | -37,091,000USD | -37,061,000USD |
| Depreciation And Amortization | — | 649,000USD | 682,000USD | 631,000USD | 1,167,000USD | 1,165,000USD | 1,184,000USD | 1,177,000USD |
| Reconciled Depreciation | — | 649,000USD | 682,000USD | 631,000USD | 1,167,000USD | 1,165,000USD | 1,184,000USD | 1,177,000USD |
| Income Tax Expense | — | — | -550,000USD | — | — | — | -9,000USD | — |
| Unclassified Operating Expenses | — | — | — | — | 12,150,000USD | — | -29,864,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 11,159,000USD | 9,994,000USD | 34,477,000USD | 13,851,000USD | 9,598,000USD | 12,361,000USD | 5,788,000USD |
| Cost Of Revenue | 3,645,000USD | 3,927,000USD | 3,525,000USD | 3,641,000USD | 984,000USD | 34,425,000USD | 23,635,000USD |
| Gross Profit | 7,514,000USD | 6,067,000USD | 30,952,000USD | 10,210,000USD | 8,614,000USD | -22,064,000USD | 5,788,000USD |
| Research Development | 109,439,000USD | 130,153,000USD | 112,075,000USD | 82,230,000USD | 52,255,000USD | 34,425,000USD | 23,635,000USD |
| Selling General Administrative | 37,914,000USD | 46,457,000USD | 38,461,000USD | 38,020,000USD | 24,322,000USD | 14,060,000USD | 16,458,000USD |
| Unclassified Operating Expenses | -3,645,000USD | -3,927,000USD | -3,525,000USD | -3,641,000USD | — | -34,425,000USD | — |
| Total Operating Expenses | 143,708,000USD | 172,683,000USD | 147,011,000USD | 116,609,000USD | 75,593,000USD | 14,060,000USD | 40,093,000USD |
| Operating Income | -136,194,000USD | -166,616,000USD | -116,059,000USD | -106,399,000USD | -66,979,000USD | -36,124,000USD | -34,305,000USD |
| Income Before Tax | -148,675,000USD | -149,114,000USD | -101,877,000USD | -99,351,000USD | -66,602,000USD | -36,127,000USD | -30,968,000USD |
| Income Tax Expense | -550,000USD | -9,000USD | 193,000USD | 70,000USD | 321,000USD | -1,819,000USD | -7,537,000USD |
| Tax Provision | -550,000USD | -9,000USD | 193,000USD | 70,000USD | 321,000USD | -1,819,000USD | -7,537,000USD |
| Net Income | -148,125,000USD | -149,105,000USD | -102,070,000USD | -99,421,000USD | -66,923,000USD | -34,308,000USD | -23,431,000USD |
| Net Income From Continuing Ops | -148,125,000USD | -149,105,000USD | -94,554,000USD | -99,421,000USD | -66,923,000USD | -34,308,000USD | -23,431,000USD |
| Ebit | -136,194,000USD | -166,616,000USD | -116,059,000USD | -99,351,000USD | -66,594,000USD | -36,107,000USD | -30,964,000USD |
| Ebitda | -132,549,000USD | -162,689,000USD | -112,534,000USD | -95,710,000USD | -65,610,000USD | -35,207,000USD | -30,213,000USD |
| Depreciation And Amortization | 3,645,000USD | 3,927,000USD | 3,525,000USD | 3,641,000USD | 984,000USD | 900,000USD | 751,000USD |
| Reconciled Depreciation | 3,645,000USD | 3,927,000USD | 3,291,000USD | 1,622,000USD | 984,000USD | 900,000USD | 751,000USD |
| Total Other Income Expense Net | -12,481,000USD | 17,502,000USD | 14,182,000USD | 7,048,000USD | 376,999USD | -3,000USD | 3,337,000USD |
| Interest Expense | — | — | — | 8,537,000USD | 8,000USD | 20,000USD | 4,000USD |
| Non Operating Income Net Other | — | — | — | 7,048,000USD | 250,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -99,421,000USD | -66,923,000USD | -34,308,000USD | -23,431,000USD |
| Interest Income | — | — | — | — | 148,000USD | 236,000USD | 1,047,000USD |
| Net Interest Income | — | — | — | — | 140,000USD | 216,000USD | 1,043,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 142,774,000USD | 148,998,000USD | 179,632,000USD | 194,984,000USD | 220,903,000USD | 273,656,000USD | 313,313,000USD | 344,334,000USD |
| Cash And Equivalents | 26,194,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 116,595,000USD | 122,381,000USD | 145,232,000USD | 155,506,000USD | 192,506,000USD | 217,323,000USD | 219,377,000USD | 237,426,000USD |
| Other Current Assets | 2,340,000USD | 2,392,000USD | 2,913,000USD | 6,177,000USD | 5,778,000USD | 6,118,000USD | 6,589,000USD | 6,583,000USD |
| Other Non Current Assets | 2,141,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 44,672,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 17,974,000USD | 19,673,000USD | 25,414,000USD | 28,058,000USD | 28,887,000USD | 28,491,000USD | 30,651,000USD | 32,159,000USD |
| Other Current Liabilities | 1,699,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 98,102,000USD | 102,018,000USD | 122,175,000USD | 141,845,000USD | 166,132,000USD | 217,222,000USD | 252,951,000USD | 281,203,000USD |
| Total Equity Including Noncontrolling Interest | 98,102,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 372,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 1,420,000USD | — | — | — | — | — | — | — |
| Net Receivables | 203,000USD | 2,363,000USD | 2,979,000USD | 2,070,000USD | 2,780,000USD | 2,740,000USD | 3,251,000USD | 2,665,000USD |
| Property Plant Equipment Net | 22,534,000USD | 23,479,000USD | 24,430,000USD | 23,602,000USD | 24,640,000USD | 38,039,000USD | 39,290,000USD | 40,058,000USD |
| Accounts Payable | 3,080,000USD | 3,503,000USD | 5,783,000USD | 3,804,000USD | 3,243,000USD | 3,873,000USD | 2,476,000USD | 2,704,000USD |
| Short Term Debt | 1,377,000USD | 1,287,000USD | 1,201,000USD | 2,687,000USD | 2,287,000USD | 1,901,000USD | 1,426,000USD | 2,372,000USD |
| Common Stock | 11,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD |
| Retained Earnings | -645,882,000USD | -621,600,000USD | -596,515,000USD | -570,027,000USD | -542,479,000USD | -488,381,000USD | -448,390,000USD | -412,900,000USD |
| Accumulated Other Comprehensive Income | -71,000USD | -23,000USD | 103,000USD | 93,000USD | 40,000USD | 167,000USD | 255,000USD | 789,000USD |
| Total Liab | — | 46,980,000USD | 57,457,000USD | 53,139,000USD | 54,771,000USD | 56,434,000USD | 60,362,000USD | 63,131,000USD |
| Other Current Liab | — | 13,889,000USD | 16,535,000USD | 19,350,000USD | 20,528,000USD | 19,888,000USD | 23,620,000USD | 24,254,000USD |
| Capital Stock | — | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD |
| Cash | — | 12,057,000USD | 12,360,000USD | 11,144,000USD | 25,201,000USD | 29,417,000USD | 16,293,000USD | 31,970,000USD |
| Cash And Short Term Investments | — | 117,626,000USD | 139,340,000USD | 147,259,000USD | 183,948,000USD | 208,465,000USD | 209,537,000USD | 228,178,000USD |
| Current Deferred Revenue | — | 994,000USD | 1,895,000USD | 2,217,000USD | 2,829,000USD | 2,829,000USD | 3,129,000USD | 2,829,000USD |
| Net Debt | — | 14,889,000USD | 14,867,000USD | 14,320,000USD | 650,000USD | -3,193,000USD | 10,194,000USD | -4,135,000USD |
| Short Long Term Debt Total | — | 26,946,000USD | 27,227,000USD | 25,464,000USD | 25,851,000USD | 26,224,000USD | 26,487,000USD | 27,835,000USD |
| Long Term Investments | — | 1,001,000USD | 3,505,000USD | 12,096,000USD | 132,000USD | 13,252,000USD | 49,125,000USD | 62,109,000USD |
| Short Term Investments | — | 105,569,000USD | 126,980,000USD | 136,115,000USD | 158,747,000USD | 179,048,000USD | 193,244,000USD | 196,208,000USD |
| Property Plant Equipment Gross | — | 37,656,000USD | 37,957,000USD | 36,495,000USD | 36,904,000USD | 52,089,000USD | 52,175,000USD | 51,865,000USD |
| Common Stock Shares Outstanding | — | 95,861,716shares | 94,536,493shares | 93,293,099shares | 93,028,698shares | 92,679,493shares | 90,317,925shares | 90,455,900shares |
| Non Current Assets Total | — | 26,616,999USD | 34,400,000USD | 39,478,000USD | 28,397,000USD | 56,333,000USD | 93,936,000USD | 106,908,000USD |
| Non Current Liabilities Total | — | 27,307,000USD | 32,043,000USD | 25,081,000USD | 25,884,000USD | 27,943,000USD | 29,711,000USD | 30,972,000USD |
| Non Currrent Assets Other | — | 2,137,000USD | 2,154,000USD | 15,733,000USD | 3,625,000USD | 5,042,000USD | 5,521,000USD | 4,741,000USD |
| Net Working Capital | — | 102,708,000USD | 119,818,000USD | 127,448,000USD | 163,619,000USD | 188,832,000USD | 188,726,000USD | 205,267,000USD |
| Unclassified Non Current Liabilities | — | 27,307,000USD | 32,043,000USD | 25,081,000USD | 25,884,000USD | 27,492,000USD | 28,926,000USD | 29,967,000USD |
| Unclassified Equity | — | 723,621,000USD | 718,569,000USD | 711,761,000USD | 708,553,000USD | 705,418,000USD | 701,068,000USD | 693,296,000USD |
| Unclassified Non Current Assets | — | — | 4,311,000USD | -11,953,000USD | — | — | — | — |
| Non Current Liabilities Other | — | — | — | — | — | 451,000USD | 785,000USD | 1,005,000USD |
| Other Assets | — | — | — | — | — | — | -7,535,000USD | — |
| Inventory | — | — | — | — | — | — | — | 798,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 175,367,000USD | 313,313,000USD | 432,209,000USD | 373,765,000USD | 442,356,000USD | 36,046,000USD | 61,933,000USD |
| Other Current Assets | 2,913,000USD | 6,589,000USD | 6,155,000USD | 7,921,000USD | 7,236,000USD | 3,193,000USD | 3,555,000USD |
| Total Liab | 53,192,000USD | 60,362,000USD | 63,808,000USD | 72,894,000USD | 54,531,000USD | 59,483,000USD | 54,470,000USD |
| Total Stockholder Equity | 122,175,000USD | 252,951,000USD | 368,401,000USD | 300,871,000USD | 387,825,000USD | -23,437,000USD | 7,463,000USD |
| Other Current Liab | 16,535,000USD | 23,620,000USD | 21,135,000USD | 16,079,000USD | 12,877,000USD | 8,968,000USD | 6,281,000USD |
| Common Stock | 9,000USD | 9,000USD | 8,000USD | 6,000USD | 6,000USD | 1,000USD | 1,000USD |
| Capital Stock | 9,000USD | 9,000USD | 8,000USD | 6,000USD | 6,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -596,515,000USD | -448,390,000USD | -299,285,000USD | -197,215,000USD | -97,794,000USD | -30,871,000USD | 3,437,000USD |
| Cash | 12,360,000USD | 16,293,000USD | 51,162,000USD | 58,338,000USD | 240,420,000USD | 15,953,000USD | 41,070,000USD |
| Cash And Short Term Investments | 139,340,000USD | 209,537,000USD | 328,827,000USD | 247,663,000USD | 375,832,000USD | 15,953,000USD | 49,471,000USD |
| Total Current Assets | 145,232,000USD | 219,377,000USD | 338,841,000USD | 260,248,000USD | 391,192,000USD | 24,306,000USD | 57,008,000USD |
| Total Current Liabilities | 25,414,000USD | 30,651,000USD | 28,302,000USD | 28,128,000USD | 25,829,000USD | 12,389,000USD | 10,078,000USD |
| Current Deferred Revenue | 1,895,000USD | 3,129,000USD | 2,847,000USD | 9,937,000USD | 8,703,000USD | 161,000USD | 717,000USD |
| Net Debt | 14,867,000USD | 10,194,000USD | -24,054,000USD | -30,592,000USD | -240,420,000USD | -14,375,000USD | -40,538,000USD |
| Short Term Debt | 1,201,000USD | 1,426,000USD | 1,200,000USD | 966,000USD | 259,000USD | 654,000USD | 532,000USD |
| Short Long Term Debt Total | 27,227,000USD | 26,487,000USD | 27,108,000USD | 27,746,000USD | 259,000USD | 1,578,000USD | 532,000USD |
| Long Term Investments | 3,505,000USD | 49,125,000USD | 51,330,000USD | 77,071,000USD | 45,302,000USD | 7,626,000USD | 0USD |
| Short Term Investments | 126,980,000USD | 193,244,000USD | 277,665,000USD | 189,325,000USD | 135,412,000USD | 0USD | 8,401,000USD |
| Net Receivables | 2,979,000USD | 3,251,000USD | 3,859,000USD | 4,664,000USD | 8,124,000USD | 5,160,000USD | 3,982,000USD |
| Accounts Payable | 5,783,000USD | 2,476,000USD | 3,120,000USD | 1,146,000USD | 3,990,000USD | 2,601,000USD | 2,537,000USD |
| Property Plant Equipment Net | 24,430,000USD | 39,290,000USD | 40,452,000USD | 34,908,000USD | 4,887,000USD | 3,502,000USD | 4,332,000USD |
| Property Plant Equipment Gross | 37,957,000USD | 52,175,000USD | 49,596,000USD | 10,678,000USD | 8,964,000USD | 3,502,000USD | 4,332,000USD |
| Accumulated Other Comprehensive Income | 103,000USD | 255,000USD | 30,000USD | -1,518,000USD | -135,000USD | 0USD | 0USD |
| Common Stock Shares Outstanding | 93,389,283shares | 90,317,925shares | 73,807,597shares | 60,801,133shares | 60,263,158shares | 27,657,420shares | 27,657,420shares |
| Non Current Assets Total | 30,135,000USD | 93,936,000USD | 93,368,000USD | 113,517,000USD | 51,164,000USD | 11,740,000USD | 4,925,000USD |
| Non Current Liabilities Total | 27,778,000USD | 29,711,000USD | 35,506,000USD | 44,766,000USD | 28,702,000USD | 47,094,000USD | 44,392,000USD |
| Non Currrent Assets Other | 2,154,000USD | 5,521,000USD | 1,586,000USD | 1,538,000USD | 975,000USD | 612,000USD | 593,000USD |
| Net Working Capital | 119,818,000USD | 188,726,000USD | 310,539,000USD | 232,120,000USD | 365,363,000USD | 11,917,000USD | 46,930,000USD |
| Unclassified Non Current Liabilities | 27,778,000USD | 28,926,000USD | 32,567,000USD | 25,129,000USD | -28,702,000USD | 38,493,000USD | 40,990,000USD |
| Unclassified Equity | 718,569,000USD | 701,068,000USD | 667,640,000USD | 499,592,000USD | 485,742,000USD | 7,432,000USD | 4,024,000USD |
| Non Current Liabilities Other | — | 785,000USD | 2,939,000USD | 1,651,000USD | 4,097,000USD | 2,830,000USD | 533,000USD |
| Other Liab | — | — | — | 17,986,000USD | 28,702,000USD | 4,847,000USD | 2,869,000USD |
| Other Assets | — | — | — | 1,538,000USD | 975,000USD | 612,000USD | 593,000USD |
| Inventory | — | — | — | -62,571,000USD | -31,111,000USD | 2,433,000USD | 3,182,000USD |
| Net Tangible Assets | — | — | — | 300,871,000USD | 387,825,000USD | -23,437,000USD | 7,463,000USD |
| Unclassified Non Current Assets | — | — | — | -1,538,000USD | — | — | — |
| Deferred Long Term Liab | — | — | — | — | 24,605,000USD | — | — |
| Short Long Term Debt | — | — | — | — | — | 847,000USD | 532,000USD |
| Long Term Debt | — | — | — | — | — | 924,000USD | — |
| Unclassified Current Assets | — | — | — | — | — | -2,433,000USD | -3,182,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,274,000USD |
| Stock Based Compensation | 4,834,000USD |
| Change To Account Receivables | -134,000USD |
| Change To Liabilities | -6,033,000USD |
| Change In Working Capital | -2,190,000USD |
| Operating Cash Flow | -49,771,000USD |
| Capital Expenditures | -73,000USD |
| Net Investments | 43,000,000USD |
| Investing Cash Flow | 42,927,000USD |
| Financing Cash Flow | 20,632,000USD |
| Change In Cash | 13,788,000USD |
| End Cash Flow | 26,194,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -25,085,000USD | -26,488,000USD | -27,548,000USD | -54,098,000USD | -39,991,000USD | -35,490,000USD | -34,684,000USD | -37,697,000USD |
| Depreciation | 649,000USD | 682,000USD | 631,000USD | 1,167,000USD | 1,165,000USD | 1,184,000USD | 1,177,000USD | 856,000USD |
| Stock Based Compensation | 2,357,000USD | 2,738,000USD | 2,931,000USD | 3,129,000USD | 3,882,000USD | 3,911,000USD | 4,069,000USD | 4,738,000USD |
| Other Non Cash Items | 46,000USD | 3,115,000USD | 210,000USD | 20,990,000USD | -285,000USD | -773,000USD | -399,000USD | -3,624,000USD |
| Change To Account Receivables | 616,000USD | -49,000USD | -149,000USD | -40,000USD | 510,000USD | -587,000USD | 253,000USD | 697,000USD |
| Change In Working Capital | -4,951,000USD | 1,867,000USD | -1,409,000USD | 554,000USD | -1,496,000USD | -4,302,000USD | -2,824,000USD | 2,861,000USD |
| Total Cash From Operating Activities | -26,984,000USD | -20,824,000USD | -25,185,000USD | -28,258,000USD | -36,725,000USD | -35,470,000USD | -32,661,000USD | -32,866,000USD |
| Capital Expenditures | -72,000USD | -216,000USD | -115,000USD | -418,000USD | -1,042,000USD | -518,000USD | -673,000USD | -2,366,000USD |
| Free Cash Flow | -27,056,000USD | -20,608,000USD | -25,300,000USD | -28,676,000USD | -37,767,000USD | -35,988,000USD | -33,334,000USD | -35,232,000USD |
| Investments | 24,057,000USD | 17,754,000USD | 10,851,000USD | 24,036,000USD | 49,381,000USD | 15,930,000USD | 26,521,000USD | 21,200,000USD |
| Total Cashflows From Investing Activities | 23,985,000USD | 17,970,000USD | 10,851,000USD | 24,036,000USD | 49,381,000USD | 15,930,000USD | 26,521,000USD | 21,200,000USD |
| Total Cash From Financing Activities | 2,696,000USD | 4,070,000USD | 277,000USD | 6,000USD | 468,000USD | 3,863,000USD | 244,000USD | 132,000USD |
| Issuance Of Capital Stock | 2,219,000USD | 3,325,000USD | 277,000USD | 468,000USD | 0USD | 2,950,000USD | 244,000USD | 669,000USD |
| Change In Cash | -303,000USD | 1,216,000USD | -14,057,000USD | -4,216,000USD | 13,124,000USD | -15,677,000USD | -5,896,000USD | -11,534,000USD |
| Begin Period Cash Flow | 12,406,000USD | 11,144,000USD | 25,201,000USD | 29,463,000USD | 16,293,000USD | 32,016,000USD | 37,912,000USD | 49,446,000USD |
| End Period Cash Flow | 12,103,000USD | 12,360,000USD | 11,144,000USD | 25,247,000USD | 29,417,000USD | 16,339,000USD | 32,016,000USD | 37,912,000USD |
| Other Cashflows From Investing Activities | 269,000USD | — | 235,000USD | 745,000USD | 452,000USD | -1,612,000USD | 1,625,000USD | -125,000USD |
| Other Cashflows From Financing Activities | 2,696,000USD | — | 277,000USD | -462,000USD | — | 913,000USD | 26,521,000USD | -537,000USD |
| Unclassified Financing Cash Flow | -2,219,000USD | — | — | — | — | — | -25,610,000USD | — |
| Unclassified Operating Cash Flow | — | -2,738,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 2,130,000USD | — | 2,491,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | -667,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -148,125,000USD | -149,105,000USD | -102,070,000USD | -99,421,000USD | -66,923,000USD | -34,308,000USD | -23,431,000USD |
| Depreciation | 3,645,000USD | 3,927,000USD | 3,525,000USD | 3,641,000USD | 984,000USD | 900,000USD | 751,000USD |
| Stock Based Compensation | 12,680,000USD | 16,706,000USD | 13,750,000USD | 11,716,000USD | 3,449,000USD | 1,002,000USD | 1,234,000USD |
| Other Non Cash Items | 21,840,000USD | -4,614,000USD | -1,178,000USD | 9,018,000USD | 904,000USD | -986,000USD | -2,293,000USD |
| Change To Account Receivables | 272,000USD | 608,000USD | 805,000USD | 3,460,000USD | -2,963,000USD | -1,178,000USD | -1,089,000USD |
| Change In Working Capital | -484,000USD | -5,114,000USD | -7,318,000USD | -4,109,000USD | 29,067,000USD | 177,000USD | -8,267,000USD |
| Total Cash From Operating Activities | -110,992,000USD | -138,200,000USD | -93,291,000USD | -90,966,000USD | -32,519,000USD | -33,215,000USD | -32,006,000USD |
| Capital Expenditures | -1,359,000USD | -6,505,000USD | -11,613,000USD | -6,454,000USD | -3,121,000USD | -1,315,000USD | -884,000USD |
| Free Cash Flow | -112,351,000USD | -144,705,000USD | -104,904,000USD | -97,420,000USD | -35,640,000USD | -34,530,000USD | -32,890,000USD |
| Investments | 103,597,000USD | 86,607,000USD | -35,539,000USD | -86,195,000USD | -173,276,000USD | 7,668,000USD | 28,117,000USD |
| Total Cashflows From Investing Activities | 102,238,000USD | 86,607,000USD | -68,183,000USD | -93,249,000USD | -176,397,000USD | 6,363,000USD | 27,233,000USD |
| Total Cash From Financing Activities | 4,821,000USD | 16,724,000USD | 154,298,000USD | 2,133,000USD | 433,429,000USD | 1,735,000USD | 172,000USD |
| Issuance Of Capital Stock | 4,070,000USD | 15,192,000USD | 152,833,000USD | 1,123,000USD | 429,847,000USD | 0USD | 0USD |
| Change In Cash | -3,933,000USD | -34,869,000USD | -7,176,000USD | -182,082,000USD | 224,513,000USD | -25,117,000USD | -4,601,000USD |
| Begin Period Cash Flow | 16,339,000USD | 51,208,000USD | 58,384,000USD | 240,420,000USD | 15,953,000USD | 41,070,000USD | 45,671,000USD |
| End Period Cash Flow | 12,406,000USD | 16,339,000USD | 51,208,000USD | 58,338,000USD | 240,466,000USD | 15,953,000USD | 41,070,000USD |
| Other Cashflows From Investing Activities | 1,140,000USD | -1,612,000USD | — | -600,000USD | -1,000,000USD | -988,000USD | 28,117,000USD |
| Unclassified Investing Cash Flow | -1,140,000USD | 8,117,000USD | -21,031,000USD | — | — | — | -28,117,000USD |
| Other Cashflows From Financing Activities | — | 1,532,000USD | 1,578,000USD | 2,133,000USD | 111,378,000USD | 270,000USD | 217,000USD |
| Change To Liabilities | — | — | — | -783,000USD | 34,895,000USD | -1,057,000USD | -6,735,000USD |
| Net Borrowings | — | — | — | 0USD | 1,031,000USD | 1,465,000USD | -45,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -182,082,000USD | 224,513,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | -11,811,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | -1,123,000USD | -111,378,000USD | — | — |
| Change To Inventory | — | — | — | — | -2,200,000USD | 1,355,000USD | -2,224,000USD |
| Sale Purchase Of Stock | — | — | — | — | 432,398,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 140,000 | USD | 0001619856-26-000036 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 2,257,000 | USD | 0001619856-26-000036 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 170,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 3,771,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 1,681,000 | USD | 0001619856-26-000008 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 9,478,000 | USD | 0001619856-26-000008 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 377,000 | USD | 0001619856-25-000071 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 1,821,000 | USD | 0001619856-25-000071 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 1,005,000 | USD | 0001619856-25-000061 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 1,662,000 | USD | 0001619856-25-000061 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 129,000 | USD | 0001619856-26-000036 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 2,224,000 | USD | 0001619856-26-000036 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 177,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 1,900,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 724,000 | USD | 0001619856-26-000008 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 9,270,000 | USD | 0001619856-26-000008 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 367,000 | USD | 0001619856-25-000071 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 1,657,000 | USD | 0001619856-25-000071 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 20,000 | USD | 0001619856-25-000061 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 3,444,000 | USD | 0001619856-25-000061 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 1,707,000 | USD | 0001619856-25-000015 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 32,770,000 | USD | 0001619856-25-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 548,000 | USD | 0001619856-24-000013 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 13,303,000 | USD | 0001619856-24-000013 |
| FY 2021Yearly · 2021-12-31 | Geography | International | 685,000 | USD | 0001619856-23-000037 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 8,913,000 | USD | 0001619856-23-000037 |
| FY 2020Yearly · 2020-12-31 | Geography | International | 358,000 | USD | 0000950170-22-004233 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 12,003,000 | USD | 0000950170-22-004233 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 439,000 | USD | 0000950170-22-004233 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 5,349,000 | USD | 0000950170-22-004233 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.